Clastogenicity of selective serotonin-reuptake inhibitors

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 558, Issue 1-2, 2004, Pages 137-144

  Bozkurt, Gokay ^a   Abay, Ercan ^a   Ates, Ibrahim ^a   Karabogaz, Goksel ^a   Ture, Mevlut ^a   Savran, Fatma Oguz ^b   Palanduz, Sukru ^b   Temocin, Kubra ^c   Algunes, Cetin ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Cells with high frequency sister chromatid exchanges (HFC); Chromosome aberration; Indicator for detecting clastogenicity; Selective serotonin reuptake inhibitors; Sertraline; Sister chromatid exchanges

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENERALIZED ANXIETY DISORDER; GENOTOXICITY; HUMAN; LYMPHOCYTE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SISTER CHROMATID EXCHANGE; TREATMENT OUTCOME;

ANIMALIA;

EID: 1242317082     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2003.11.005     Document Type: Article

References (35)

1. Davies T.S., Klowe W.M. Preclinical toxicological evaluation of Sertraline hydrochloride. Drug. Chem. Toxicol. 21(2):1998;163-179.
2. Sweirenga S.H.H., Heddle J.A., Signal E.A.et al. Recommended protocols based on survey on current practice in genotoxicity testing labs. Part IV. Chromosome aberration and sister chromatid exchange in Chinese hamster ovary, lung andhuman lymphocyte cultures. Mut. Res. 246:1991;301-322.
3. Hoerauf K.H., Schroegendorfer K.F., Wiesner G.et al. Sister chromatid exchanges in human lymphocytes exposed to isoflurane and nitrous oxide in vitro. Br. J. Anaesth. 82:1999;268-270.
4. Nakanishi Y., Schneider E.L. In vivo sister-chromatid exchange: a sensitive measure of DNA damage. Mutat. Res. 60:1979;329-337.
5. Gebhart E. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Hum. Genet. 58:1981;235-254.
6. A.V. Carrano, D.H. Moore, The rationale and methodology for quantifying sister chromatid exchange in humans, in: J.A. Heddle (Ed.), Mutagenicity: New Horizons in Genetic Toxicology, Academic Press, New York, 1982, pp. 267-304.
7. Haber J.E. DNA recombination: the replication connection. Tr. Biochem. Sci. 24:1999;271-275.
8. Sonoda E., Sasaki M.S., Morrison C.et al. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol. 19:1999;5166-5169.
9. Li G.C., Li X., Nagasawa H.et al. Ku70: a candidate tumor suppressor gene for murine T Cell lymphoma. Mol. Cell. 2:1998;1-8.
10. Kanaar R., Hoeijmakers J.H.J., Van Gent D.C. Molecular mechanisms of DNA double-strand break repair. Trends Cell. Biol. 8:1998;483-489.
11. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Nature. 379:1996;606-612.
12. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 95(7):1998;4029-4034.
13. Munoz-Bellido J.L., Munoz-Criado S., Garcìa-Rodrìguez J.A. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int. J. Antimicrob. Agents. 14(3):2000;177-180.
14. Degner D., Grohmann R., Bleich S.et al. New antidepressant drugs. What side effects and interactions are to be expected? M.M.W. Fortschr. Med. 49(5):2000;35-38.
15. McRae A.L., Brady K.T. Review of sertraline and its clinical applications in psychiatric disorders. Exp. Opin. Pharmacother. 2(5):2001;883-892.
16. Albertini R.J., Anderson D., Douglas G.R.et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat. Res. 463:2000;111-172.
17. Perry P., Wolff S. New giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158.
18. A.D. Bloom, Guidelines for cytogenetic studies in mutagen-exposed human populations, in: A.D. Bloom (Eds.), Guidelines for Studies of Human Populations Exposed to Mutagenic and Peproductive Hazards, March of Dimes Birth Defects Foundation, New York, 1981, pp. 3-35.
19. Gebhart E. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Hum. Genet. 58:1981;235-254.
20. Bonassi S., Fontana V., Ceppi M.et al. Analysis of correlated data in human biomonitoring studies. The case of high sister chromatid exchange frequency cells. Mutat. Res. 438:1999;13-21.
21. Y. Ishii, M. Watatani, Cell-stage dependence of formation of SCEs and chromosomal aberrations, in: R.R Tice, A. Hollander (Eds.), Sister Chromatid Exchanges, Plenum Press, New York, pp. 173-180.
22. Das B.C. Factors that influence formation of sister chromatid exchanges in human blood lymphocytes. CRC Crit. Rev. Toxicol. 19:1988;43-46.
23. Baker E.S., Connor T.H. Monitoring occupational exposure to cancer chemotherapy drugs. Am. J. Health System Pharm. 53(22):1996;2713-2723.
24. Bonassi S., Fontana V., Ceppi M.et al. Analysis of correlated data in human biomonitoring studies, the case of high sister chromatid exchange frequency cells. Mutat. Res. 438:1999;13-21.
25. Ponzanelli I., Landi S., Bernacchi F., Barale R. The nature of high frequency sister chromatid exchange cells (HFCs). Mutagenesis. 12:1997;329-333.
26. Tucker J.D., Ashworth L.K., Johnston G.R.et al. Variation in the human lymphocyte sister-chromatid exchange frequency: results of a long-term study. Mutat. Res. 204:1988;435-441.
27. Carrano A.V., Natarajan A.T. Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 204:1988;379-406.
28. Lambert B., Bredberg A., McKenzie W.et al. Sister chromatid exchange in human populations: the effect of smoking. Cytogenet. Cell. Genet. 33:1982;62-67.
29. Maki-Paakkanen J., Walles S., Osterman-Golkar S.et al. Single-strand breaks, chromosome aberrations, sister-chromatid exchanges and micronuclei in blood lymphocytes of workers exposed to styrene during the production of reinforced plastics. Environ. Mol. Mutagen. 17:1991;27-31.
30. Karelova J., Jablonicka A., Gavora J.et al. Chromosome and sister-chromatid exchange analysis in peripheral lymphocytes, and mutagenicity of urine in anesthesiology personnel. Int. Arch. Occup. Environ. Health. 64:1992;303-306.
31. De Jong G., van Sittert N.J., Natarajan A.T. Cytogenetic monitoring of industrial populations potentially exposed to genotoxic chemicals and of control populations. Mutat. Res. 204:1988;451-464.
32. Fischman H.K., Kelly D.D. Chromosomes and Stress. Int. J. Neurosci. 99:1999;201-219.
33. Fischman H.K., Pero R., Kelly D.D. Psychogenic stress reduces chromosomal and DNA damage. Int. J. Neurosci. 84:1996;219-227.
34. McDiarmid M.A., Jacobson-Kram D., Koloder K., Deeter D.P., Lachiver R.M., Scott B., Petrucelli B.P., Gustavison D., Putman D. Increased frequencies of sister chromatid exchange in soldiers deployed to Kuwait. Mutagenesis. 10(3):1995;263-265.
35. Huttner E., Matthies U., Nikolova T., Ehrenreich H. A follow-up study on chromosomal aberrations in lymphocytes of alcoholics during early, medium, and long-term abstinence, alcoholism. Clin. Exp. Res. 23(2):1999;344-348.